Melatonin Side Effects: What the Data Shows | Slumbr

Melatonin has one of the gentler side-effect profiles in sleep medicine, and most of what people experience is dose-related rather than inherent to the molecule. Vivid dreams and morning grogginess are the two complaints that come up again and again. Both are far more common at the 5 and 10 mg doses widely sold than at the 0.3 to 1 mg the evidence actually supports. In the South African registered prolonged-release product's own clinical trials, every adverse reaction listed fell into the "uncommon" band or rarer, meaning fewer than one in a hundred participants.

Key takeaways

The most frequently reported effects are headache, vivid or unsettled dreams, and next-morning grogginess.
Most of these are dose problems, not melatonin problems. Dropping to 0.3 to 1 mg resolves a large share of them.
In the SA-registered prolonged-release product's trials, no adverse reaction reached the "common" frequency band. All were uncommon (fewer than 1 in 100) or rarer.
Melatonin can make you drowsy enough to matter for driving. The approved SA information says so explicitly.
Several drug interactions are real and documented, and one combination is to be avoided outright.

The two complaints you will actually have

Vivid dreams and unsettled dream content

This is the effect people mention most, and it is usually not sinister. Dream recall tends to increase when sleep architecture shifts, and it often settles within the first week or two of use. It is also strongly dose-related: far more commonly reported by people taking 5 or 10 mg than by people taking a fraction of a milligram.

If dreams are disturbing rather than merely memorable, that is a reason to reduce the dose or stop. If it persists, talk to a doctor rather than push through. The registered prolonged-release product's professional information does list abnormal dreams and nightmares among its uncommon adverse reactions, alongside irritability, restlessness and anxiety.

Morning grogginess

The classic "melatonin hangover." It is almost always a dose-too-high problem, and it has a straightforward explanation: melatonin is cleared from the body fairly quickly, which is why your own night-time signal fades before dawn. Take ten times a physiological amount and there is still melatonin circulating when you need to be awake.

The fix is nearly always to go down, not up. Dropping to 0.3 to 0.5 mg resolves it for most people. If it persists at a low dose, the timing is the next thing to check.

What the South African registered product's data shows

South Africa has a registered prolonged-release melatonin tablet, a Schedule 4 prescription-only medicine for adults aged 55 and over. Because it is a registered medicine rather than a supplement, its approved professional information carries a full adverse-reaction table from clinical trials. That makes it the most rigorous melatonin safety data available in a South African regulatory document, and it is worth reading in both directions.

The reassuring direction: the professional information records the most commonly reported adverse reactions as headache, nasopharyngitis (common-cold symptoms), back pain and joint pain. Even these sit in the "uncommon" frequency band, defined as at least 1 in 1,000 but fewer than 1 in 100. Nothing appears in the "very common" or "common" bands at all. For a medicine taken nightly, that is a genuinely mild profile.

The other direction: the table is not empty. Listed as uncommon are irritability, nervousness, restlessness, abnormal dreams, nightmares, anxiety, migraine, headache, lethargy, dizziness, somnolence, abdominal pain, dry mouth, nausea, night sweats, rash, hypertension and abnormal liver function tests, among others. Listed as rare are effects including altered mood, aggression, agitation, disorientation, depressed mood and depression, syncope, memory impairment, restless legs syndrome, blurred vision, palpitations and angina.

Two caveats matter for interpreting this. These frequencies describe that product, a 2 mg prolonged-release tablet taken by adults aged 55 and over, and should not be assumed to transfer unchanged to low-dose immediate-release melatonin. And "uncommon" is not "never." If you experience low mood, disorientation or agitation after starting melatonin, that is a reason to stop and speak to a doctor, not to assume it must be unrelated.

Drowsiness is a real effect, and it matters for driving

It is worth being blunt about this, because "melatonin is not a sedative" is a point we make often and it can be misread. Melatonin's therapeutic action is on the body clock rather than on sedation. But it can still make you drowsy, and the approved South African information is explicit: the product may cause somnolence or dizziness, and patients should not drive or operate machinery after taking it.

Take it when you are settled for the night, not when you might still need to drive.

Interactions worth knowing about

The registered product's professional information documents a number of interactions. These are the ones with practical consequences:

Fluvoxamine (an antidepressant) dramatically increases melatonin levels by blocking its breakdown. The approved information states the combination should be avoided.
Cimetidine raises melatonin levels substantially; caution is advised.
Oestrogens, including in contraceptives and hormone replacement therapy, increase melatonin levels by slowing its metabolism.
Carbamazepine and rifampicin work the other way, reducing melatonin levels.
Quinolone antibiotics can increase melatonin exposure.
Alcohol should not be taken with it, because it reduces the effect on sleep.
Benzodiazepines and z-drugs (zolpidem, zopiclone, zaleplon): melatonin may enhance their sedative effect. All sedatives can be expected to be additive.
Smoking lowers melatonin levels.

Our companion article on whether melatonin is safe covers the broader interaction picture, including anticoagulants and glucose control, in more depth.

Who should not take it without medical advice

The approved South African information for the prolonged-release product is restrictive in ways that are worth knowing even if you are considering a low-dose product:

Pregnancy and breastfeeding: safety has not been established. It should not be used, and mothers taking it should not breastfeed.
Under 18s: not recommended, on the grounds of insufficient safety and efficacy data.
Autoimmune disease: not recommended, because no clinical data exist in this group.
Liver impairment: not recommended; melatonin clearance is already reduced.
Kidney impairment: caution advised, as the effect on melatonin handling has not been studied.

Add to that anyone on the interacting medicines above, and anyone whose sleep problem comes with loud snoring, witnessed pauses in breathing or heavy daytime sleepiness. In that last case the priority is assessment for an underlying sleep disorder rather than any supplement.

The side effect nobody counts

There is one cost of melatonin that never appears in an adverse-reaction table: the months spent treating the wrong problem.

Most people who reach for melatonin have chronic insomnia, meaning sleep difficulty at least three nights a week for three months or more, with daytime consequences. Melatonin was never designed for that. It is a timing signal, and insomnia is generally not a timing disorder. The recommended first-line treatment for chronic insomnia is CBT-I (cognitive behavioural therapy for insomnia), which has better evidence than any medicine and no side-effect table at all.

Taking a well-tolerated product that does not address your problem feels harmless. Losing half a year to it is not.

Frequently asked questions

Does melatonin cause nightmares? Vivid or unsettled dreams are among the more commonly reported effects, and nightmares are listed as an uncommon adverse reaction in the SA-registered prolonged-release product's information. They are strongly dose-related and often settle within a week or two. Persistently disturbing dreams are a reason to reduce the dose or stop.

Why do I feel groggy the morning after taking melatonin? Almost always because the dose was too high for your body to clear before waking. Reducing to 0.3 to 0.5 mg resolves it for most people.

Can melatonin cause headaches? Yes. Headache is among the most frequently reported adverse reactions in the registered product's trials, though still within the uncommon frequency band.

Is it safe to drive after taking melatonin? No. The approved South African information states the product may cause somnolence or dizziness and that patients should not drive or operate machinery after taking it.

Can melatonin affect my mood? The registered product's information lists altered mood, depressed mood and depression as rare adverse reactions, and irritability and anxiety as uncommon ones. If your mood changes after starting melatonin, stop and speak to a doctor.

Are the side effects worse at higher doses? The effects people actually notice, grogginess and vivid dreams, are clearly dose-related and become considerably more common at the 5 and 10 mg doses sold internationally. There is no clinical reason to take those doses.

Melatonin Side Effects: Vivid Dreams, Morning Grogginess, and What the Data Actually Shows